Cyclosporin A-Derivative 1

Research use only, not for human use.

Cyclosporin A-Derivative 1 is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1.

Cyclosporin A-Derivative 1 is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1. (In Vitro):Cyclosporin A-Derivative 1 is a non-immunosuppressive Cyclosporine A derivative. The cyclosporin is acylated on the butenyl-methyl-threonine side chain and then subjected to a ring-opening reaction (the ring opens between the sarcosine and the N-methyl-leucine residues). Cyclosporin A-Derivative 1 is a linear peptide intermediate.

Cyclosporin A-Derivative 1 is a non-immunosuppressive Cyclosporine A derivative. The cyclosporin is acylated on the butenyl-methyl-threonine side chain and then subjected to a ring-opening reaction (the ring opens between the sarcosine and the N-methyl-leucine residues). Cyclosporin A-Derivative 1 is a linear peptide intermediate.

——

——

Others

Other Targets

——

——

——

1487360-85-9

1364.5

C65H118BF4N11O14

>98% (HPLC)

——

——

Sequence:Leu-Val-Leu-Ala-D-Ala-Leu-Leu-Val-{Aaa}-{Abu}-{Sar}

(-20℃)

With Ice Pack

≥ 2 years